MARKET

ALKS

ALKS

Alkermes Plc
NASDAQ
26.88
+0.55
+2.09%
After Hours: 26.95 +0.07 +0.26% 17:30 12/05 EST
OPEN
26.13
PREV CLOSE
26.33
HIGH
26.95
LOW
26.10
VOLUME
3.07M
TURNOVER
0
52 WEEK HIGH
33.71
52 WEEK LOW
22.01
MARKET CAP
4.49B
P/E (TTM)
21.79
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ALKS last week (1127-1201)?
Weekly Report · 1d ago
AMKR, ALKS and CLFD are among after hour movers
Amkr, alks, ofix, forr, clfd, jrvr, akro, lfmd, tern, fnch are among the day's movers. Terns pharmaceuticals and forrester research were among the top gainers.
Seeking Alpha · 4d ago
3 Top Growth Stocks to Buy for December 2023
NASDAQ · 4d ago
The most crowded pharma longs and shorts, according to UBS
The most crowded pharma longs and shorts, according to ubs. Crowding is a sentiment metric that measures popularity in positioning. United therapeutics corp. Is the most crowded longs in the u.s. Pharmaceutical sector. Ubs measures crowding based on prime brokerage data and 13f filings.
Seeking Alpha · 4d ago
Alkermes To Participate In 6th Annual Evercore ISI HealthCONx Conference At 10:00 AM ET
NASDAQ · 6d ago
Top 10 valuation stocks with highest forward P/E
Top 10 valuation stocks with highest forward p/e ranked from highest forward price-to-earnings ratio. Li auto, pgti, alks, li, mgnx, desp, stne, beke are among the top 10 rated stocks from a valuation perspective.
Seeking Alpha · 11/28 16:56
Alkermes To Participate In Piper Sandler 35th Annual Healthcare Conference At 11:00 AM ET
NASDAQ · 11/28 15:00
Weekly Report: what happened at ALKS last week (1120-1124)?
Weekly Report · 11/27 09:07
More
About ALKS
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.

Webull offers Alkermes Plc stock information, including NASDAQ: ALKS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALKS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALKS stock methods without spending real money on the virtual paper trading platform.